-
Global Immunotherapy Drug Market Projected to Reach $467.4 Billion by 2030
15 Jan 2026 18:44 GMT
… analyzes the global immunotherapy drug market, covering current … &D by pharmaceutical and biotech firms accelerates clinical … :
Unlike chemotherapy, immunotherapy drugs work by mobilizing the … the global biologic therapeutic drug market, analyzing trends, …
-
This cancer is stubborn, but new drug regimen shows promise
15 Jan 2026 17:18 GMT
… it had awarded the drugmaker a new, controversial … combination of two immunotherapy drugs, Tecvayli and Darzalex Faspro … other companies developing cancer drugs. One major uncertainty, … drug - developed by Johnson & Johnson and partner Legend Biotech …
-
Alpha Buying: Managing Biotech Risk With Insider Clues
15 Jan 2026 16:57 GMT
… better.
And then biotech does what biotech always does. It … commercial risk is real. Launching drugs is hard. Payers negotiate. … the most unforgiving arena in drug development. Annexon's … limited effective treatments. Their drug is a small molecule, …
-
<![CDATA[Market Access in 2026: Will Cash Models Take Over for Consumers Wanting Greater Access and How Will This Impact Pharmacy Distribution Models?]]>
15 Jan 2026 16:37 GMT
… trade for the pharmaceutical and biotechnology industries. This conference … trade tariffs, and drug supply serialization.
After 3 … for at least one medication, Roth observed that the … collaborations, IRA impact, drug shortages, specialty channel distribution …
-
MATC converts downtown campus space into biotech lab
15 Jan 2026 19:44 GMT
… to pursue careers in the biotechnology industry,” said Abigail Cannon, … Career Pathway, in a statement. “Biotechnology laboratory technicians have been identified … training and learn techniques for drug development, molecular biology, genetics, …
-
Novo Nordisk Foundation commits DKK 5.5 billion to scale European biotech innovation
15 Jan 2026 15:47 GMT
… . Venture capital investment in Danish biotech has increased more than fourfold … focus on life sciences and biotechnology. At the same time, it … increasingly relevant for drug discovery, diagnostics and industrial biotech.
A European ambition …
-
It’s crunch time for US biopharma M&A. Can drugmakers strike deals despite persisting anxieties?
15 Jan 2026 14:34 GMT
Between regulatory upheaval, drug pricing measures, an escalating … and more last year, drugmakers have had plenty of reasons … Anxiety drivers
Last year presented pharma leaders with a series of … country’s rapid ascent in biotech innovation, and U.S. …
-
Chicago Atlantic Provides $16.5 Million Term Loan to Ocular Science, Inc., a Leading Biotech Company Focused on Compounded Ophthalmic Products
15 Jan 2026 14:41 GMT
… affordable medication available to patients.
“Ocular Science is a leading biotech company … , Calif., is a leading biotech company founded in 2015 by … SERVICES HEALTH FINANCE GENERAL HEALTH PHARMACEUTICAL OPTICAL BIOTECHNOLOGY
SOURCE: Chicago Atlantic
Copyright …
-
Alamo BioCenter’s BioSpark Program Celebrates Pilot-Year Success in Middle and High School Biotech Training
15 Jan 2026 13:56 GMT
Hands-on biotech training delivers credentials, research projects, and real lab access for San Antonio students—fueling expansion in the year ahead.
SAN ANTONIO, TX, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- BioSpark, a San Antonio– …
-
Cardiac Biotech Solutions Activates China Production Pipeline for MyCardia AT and Moves into Final NMPA Submission Phase
15 Jan 2026 13:00 GMT
LAS VEGAS, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Cardiac Biotech Solutions, Inc. (OTCID: CBSC) (“CBSC” or the “Company”), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring products, today provided an update on the execution …